The Australian Government has appointed Kathryn North AC as the new Chair of the Australian Medical Research Advisory Board (AMRAB).
The AMRAB determines the Australian Medical Research and Innovation Strategy and Priorities that guide how funds from the $650 million Medical Research Future Fund are distributed.
Professor North is a distinguished paediatric physician, neurologist, and clinical geneticist renowned for her leadership in research translation and genomic medicine.
She brings a wealth of experience across clinical, academic, and policy domains, making her exceptionally well suited to guide AMRAB's strategic direction.
Her contributions to medical research have been recognised through numerous prestigious awards and she has served on multiple government committees and advisory bodies, including as chair of the National Health and Medical Research Council.
Professor North replaces Professor Ian Frazer AC, the inaugural chair of the AMRB.
Professor Frazer stepped down from his role in February 2025 after leading three iterations of the Australian Medical Research and Innovation Strategy and Priorities.
Quotes attributable to Minister Butler:
"Australia has a strong track record in medical research and discoveries. Professor North will bring a wealth of knowledge and experience to further advance Australia's research capability.
"She is widely regarded as one of Australia's most influential clinician scientists, dedicated to translating research into real-world health improvements.
"I thank Professor Frazer for his leadership and service and extend my sincere thanks to Professor Caroline Homer AO, AMRAB Deputy Chair, for her stewardship during the interim period."
Quotes attributable to Professor Kathryn North:
"With the increasing alignment between the Medical Research Future Fund and National Health and Medical Research Council, there is a golden opportunity to bridge the gap between scientific discovery and real-world impact more rapidly than ever before.
"I look forward to contributing to the strategic work of AMRAB to strengthen and sustain our vibrant health and medical research sector."
